Russian Health Minister Mikhail Murashko has said that clinical trials had been completed at the state research facility in Moscow.

Russian Health Minister Mikhail Murashko has said that clinical trials had been completed at the state research facility in Moscow, the Gamaleya Institute, and that the vaccine was now being registered.

“The vaccine against coronavirus infection, developed by the Gamaleya center, has completed clinical studies, and a package of documents is being prepared for the registration procedure”, Murashko said.

Mikhail Murashko told that once it is authorized, vaccines will start to be used in special groups, first of all on doctors and teachers, and that they plan wider vaccinations for October.